StockSelector.com
  Research, Select, & Monitor Monday, June 25, 2018 3:36:37 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ironwood Pharmaceuticals, Inc.$18.68($.66)(3.41%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ironwood Pharmaceuticals, Inc. has an overall rank of 7004 out of 7142 stocks based on 5 positive rankings and 12 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Ironwood Pharmaceuticals is $269.56. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ironwood Pharmaceuticals is ranked 89.
Estimated Revenue Growth
Ironwood Pharmaceuticals rank is 380
10 Day Gain
Ironwood Pharmaceuticals rank is 436
90 Day Gain
Ironwood Pharmaceuticals rank is 555
Historic Revenue Growth
Ironwood Pharmaceuticals rank is 980
Negative Rankings
Price-to-Book
Ironwood Pharmaceuticals rank is 20
Debt-to-Equity
Ironwood Pharmaceuticals rank is 23
Negative ROE
Ironwood Pharmaceuticals rank is 28
Overbought Stochastics
Ironwood Pharmaceuticals rank is 128
Missed Whisper
According to EarningsWhispers.com, Ironwood Pharmaceuticals missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
High Put/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 1.33 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 389.
High vPut/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 2.00 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 437.
Price-to-Sales
Ironwood Pharmaceuticals rank is 592
Negative Net Margin
Ironwood Pharmaceuticals rank is 640
Down EPS Surprise
Ironwood Pharmaceuticals missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Ironwood Pharmaceuticals rank is 927
Negative Cash Growth
Ironwood Pharmaceuticals rank is 1312







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.